The majority of reported studies using human umbilical cord blood (hUCB) cells showed
improvement in the outcomes. Cardiac functional improvements were almost universally
reported as evaluated by: increased ejection fraction; improved wall motion; lowered LV
end-diastolic pressure; and increased cardiac contraction as determined by the
maximum slope of LV pressure.
clinmedicine.9-4-342
